Headlines on the fledgling marijuana industry.
|ACB||Aurora Cannabis Inc.||
|CRON||Cronos Group Inc.||
|WEED||Canopy Growth Corp.||
|TLRY||Tilray Brands Inc. Cl 2||
More from Cannabis Watch
Cowen drops coverage of U.S. pot stocks on acquisition by Toronto-Dominion Bank
Cowen analyst Vivien Azer will continue analysis of cannabis sector but will no longer follow seven stocks including Curaleaf, Green Thumb and Trulieve.
NJ’s Suzan Nickelson launches first cannabis dispensary in the Garden State owned by an African American woman
Medical cannabis operator opens Holistic Solutions in southern New Jersey with a strain called 'Girlie' after her mother's nickname.
Twitter will allow cannabis ads in parts of the United States
Twitter permits approved cannabis and CBD products to target U.S. consumers, with restrictions including pre-authorization and no direct weed sales
New York’s newest cannabis dispensary opens as state rolls out social-equity model
Union Square Travel Agency: A Cannabis Store is the newest state-licensed adult-use retail store to open under the state's social-equity program.
Canopy Growth lays off 800 as its slashes spending and posts wider-than-expected loss
CEO David Klein says 'changes are difficult but necessary to drive our business to profitability and growth'
Will $2 billion merger of Cresco and Columbia Care reach the finish line? Analysts see ‘market doubt’ for cannabis deal.
Cresco spokesperson says the cannabis company still plans to close acquisition of Columbia Care despite the uncertainty in the marketplace flagged by Viridian Capital.
There’s a new ‘luxury’ cannabis company run by former car execs — and they’re using jet engine tech in production
Entrepreneurs from the car world offer solvent-free cannabis products to luxury customers craving a premium experience
Is the cannabis gold rush over? Moves by Curaleaf, Ayr, Akerna and other companies point to tough times.
Ayr scraps $55 million Chicago deal, Curaleaf cuts staff, Organigram receives delisting notice and Akerna moves out of the pot business altogether.
Corrected Curaleaf cutting staff as it exits three U.S. states
Curaleaf said it will pull out of California, Colorado and Oregon in the face of cannabis price compression and challenges from illicit sales
FDA says it will not regulate CBD and calls on Congress to act
FDA says CBD and other cannabis-derived products require oversight that it can not currently provide given potential safety risks.
New York opens new cannabis stores, issues more licenses as illicit stores thrive
New York state's second and third cannabis dispensaries are opening, and state awards 30 fresh licenses to nonprofits and people hurt by the war on drugs.
States with legalized recreational cannabis have lower retail codeine use, DEA data shows
Opioid-tracking data from the Drug Enforcement Administration shows 26% less retail-pharmacy codeine distribution in states with legal adult-use cannabis.
American Express, Citizens registered to lobby for Safe Banking cannabis measure: report
S&P 500 components American Express and Citizens Financial were listed in filings as lobbying for the Secure and Fair Enforcement Banking Act (SAFE)
Quiet giant NCH readies probiotic cannabis cultivation product under the name ActPro
Privately-held Texas company NCH branches out into probiotics to boost cannabis yields with less water and fertilizer, with trials now underway.
4 states eye cannabis measures as Congress stalls
Minnesota, South Carolina, Kentucky and Oklahoma will consider cannabis initiatives in 2023, while Wisconsin's governor is calling for dialogue on the issue.
Cannabis stocks end a dismal year near all-time lows
Despite revenue growth and new states opening up legal sales, cannabis companies have been left out in the cold by institutional investors and shunned by retail investors.
New York marks first legal cannabis sale as prohibition officially ends in the Empire State
With the opening of its first store, New York state meets its deadline to launch retail cannabis sales by the end of 2022
Federal spotlight shifts to regulatory re-scheduling of cannabis
With a cannabis banking measure dead in Congress, attention now shifts to President Biden's re-scheduling of cannabis as a Schedule I substance under federal law.
U.S. FDA weighs regulations on cannabis products in food and diet supplements
FDA officials tell the Wall Street Journal that safety concerns around CBD may cause the agency to publish its first guidelines on cannabis-derived products.
Cannabis beverage maker Cann targets social alcohol drinkers
Cann co-founders Jake Bullock and Luke Anderson East Coast push after carving out strong market share offering THC drinks as an alternative to alcohol